Article

PFHpA alters lipid metabolism and increases the risk of metabolic dysfunction-associated steatotic liver disease in youth—a translational research framework

2024-07-03

Abstract excerpt

To address the growing epidemic of liver disease, particularly in pediatric populations, it is crucial to identify modifiable risk factors for the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD). Per- and polyfluoroalkyl substances (PFAS) are persistent ubiquitous chemicals and have emerged as potential risk factors for liver damage. However, their impact on the etio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a0ddc049-b843-50d3-9ea0-17e29bb0839c
DOI: 10.1101/2024.07.01.24309775

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

PFHpA alters lipid metabolism and increases the risk of metabolic dysfunction-associated steatotic liver disease in youth—a translational research frameworkDOI 10.1101/2024.07.01.24309775Read

Integrated Spheroid-to-Population Framework for Evaluating PFHpA-Associated Metabolic Dysfunction and Steatotic Liver DiseaseSemantic proximity Read

Metabolic and phenotypic changes induced by PFAS exposure in two human hepatocyte cell models.Semantic proximity Read

Effects of mixed exposure to PFAS on adolescent non-alcoholic fatty liver disease: Integrating evidence from human cohorts, toxicogenomics, and animal models to uncover mechanisms and potential target sitesSemantic proximity Read

Associations between per- and polyfluoroalkyl substances and metabolic dysfunction-associated steatotic liver disease in adolescents and young adults: modifying roles of age, lifestyle factors, and PNPLA3 genotype.Semantic proximity Read

Genome-Scale Metabolic Modeling Predicts Per- and Polyfluoroalkyl Substance-Mediated Early Perturbations in Liver MetabolismSemantic proximity Read

Integrating high-throughput phenotypic profiling and transcriptomic analyses to predict the hepatosteatosis effects induced by per- and polyfluoroalkyl substances.Semantic proximity Read

Unraveling MASLD Through the Use of Omics TechnologiesSemantic proximity Read

Subchronic Toxicity Assessment of Perfluoroalkyl Substances by Mixed Exposure of Nine Substances at Daily Intake Relevant ConcentrationSemantic proximity Read

PFHxS Exposure and the Risk of Non-Alcoholic Fatty Liver DiseaseSemantic proximity Read

High-throughput transcriptomic analysis of human primary hepatocyte spheroids exposed to per- and polyfluoroalkyl substances (PFAS) as a platform for relative potency characterizationSemantic proximity Read

The Interplay between Endocrine-Disrupting Chemicals and the Epigenome towards Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comprehensive ReviewSemantic proximity Read

Chronic exposure to PFAS triggers systems-level cellular reprogramming independent of their bioaccumulationSemantic proximity Read